Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-01-04
1989-05-23
Rosen, Sam
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514926, 514927, A61K 31215
Patent
active
048331570
ABSTRACT:
A therapeutic method for inhibiting gastric secretion in an individual for whom such therapy is indicated is disclosed. The method comprises administering to such an individual an effective inhibitory amount of certain derivatives of 15-deoxy-16-hydroxy-prostaglandin E.sub.1 esters.
REFERENCES:
patent: 3965143 (1976-06-01), Collins
patent: 4197407 (1980-04-01), Wissner et al.
Biddlecom William G.
Kluender Harold C.
Woessner Warren D.
Boguslaski M. G.
McNeil J.
Miles Inc.
Rosen Sam
LandOfFree
Methods of inhibitng gastric secretion with prostaglandin deriva does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibitng gastric secretion with prostaglandin deriva, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibitng gastric secretion with prostaglandin deriva will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1731030